NICE Systems Ltd. (NASDAQ:NICE) shares increased 0.98% in last trading session and ended the day at $57.56. NICE Gross Margin is 65.10% and its has a return on assets of 8.20%. NICE Systems Ltd. (NASDAQ:NICE) quarterly performance is -9.92%.
On 30 September, NICE Systems Ltd. (NASDAQ:NICE) released the latest version of NICE Fizzback, which enables greater customization, flexibility, and ease of use to improve organizations’ responsiveness to customer feedback.
ReneSola Ltd. (NYSE:SOL) ended the last trading day at $1.35. Company weekly volatility is calculated as 8.16% and price to cash ratio as 3.20. ReneSola Ltd. (NYSE:SOL) showed a weekly performance of 13.45%.
On 6 October, ReneSola Ltd. (NYSE:SOL) announced that it has sold its 16.5 MW Membury utility scale project in the United Kingdom to Foresight Solar Fund Limited (“FSFL”). This represents ReneSola’s third project sale to Foresight Group, a leading, independent infrastructure and private equity investment manager, following the sale of its 34.6 MW Port Farm project to FSFL in August 2015 and its 6.4 MW Field House project in July 2015 to other funds managed by Foresight.
On 09 October, Anadigics, Inc. (NASDAQ:ANAD) shares fell -3.70% and was closed at $0.26. ANAD EPS growth in last 5 year was 13.30%. Anadigics, Inc. (NASDAQ:ANAD) year to date (YTD) performance is -65.33%.
Zacks upgraded shares of Anadigics, Inc. (NASDAQ:ANAD) from a sell rating to a hold rating in a report issued on Monday morning, Market Beat Ratings reports.
United Continental Holdings, Inc. (NYSE:UAL) shares increased 6.60% in last trading session and ended the day at $55.71. UAL Gross Margin is 28.60% and its has a return on assets of 6.90%. United Continental Holdings, Inc. (NYSE:UAL) quarterly performance is -1.21%.
On 2 October, United Continental Holdings, Inc. (NYSE:UAL) boss Oscar Munoz declares in the letter that the merger with Continental Airlines has failed to live up to the expectations of both passengers and employees.
Gilead Sciences Inc. (NASDAQ:GILD) caters to the Healthcare space. It has a net profit margin of 51.50% and weekly performance is 2.41%. On the last day of trading company shares ended up at $100.65. Gilead Sciences Inc. (NASDAQ:GILD) distance from 50-day simple moving average (SMA50) is -6.41%.
On 28 September, Gilead Sciences Inc. (NASDAQ:GILD) announced that its investigational drug paired with the blockbuster drug Sovaldi scored high cure rates with six genotypes of the hepatitis C virus in late-phase clinical trials for treatment of the disease.
Leave a Reply